Novo Nordisk again increased its offer for Metsera as its takeover battle with Pfizer for the obesity startup escalates. CEO Mike Doustdar commented on its bid at the White House on Thursday during a press conference with Trump. (Source: Bloomberg)
www.bloomberg.com
#Novo #CEO #Doustdar #Pfizer #Metsera #Takeover #Battle #Bid #Higher
Novo CEO Doustdar to Pfizer on Metsera Takeover Battle: ‘Bid Higher’
